PAIN Publishes Supplement of Review Articles From 2015 NeuPSIG Congress

Jan 27, 2016

Pain.Supplement.Feb16

IASP has published a supplement to PAIN that features reviews of 14 selected plenary and workshop sessions conducted at the 5th International Congress on Neuropathic Pain in Nice, France, last May. The meeting was organized by NeuPSIG, the Neuropathic Pain Special Interest Group of IASP, and complemented the 2015 Global Year Against Neuropathic Pain.

The supplement was edited by Nadine Attal of INSERM and the University Versailles Saint Quentin, in France, and Nanna Brix Finnerup of the Danish Pain Research Center of Aarhus University in Denmark.

The peer-reviewed articles cover major recent innovative developments in basic sciences, clinical research, and treatment applications in the field of neuropathic pain. They provide insight into recent advances in pathophysiological research in neuropathic pain, focusing on potassium and calcium channels, the endocannabinoid system, immune cells, and the renin angiotensin system, and envisaging potential therapeutic developments including:

  • angiotensin receptor type 2 antagonists, a particularly  promising therapeutic candidate, which have recently been reported to be clinically beneficial in neuropathic pain
  • futuristic therapeutic advances, such as the potentialities of cell transplants for the treatment of the “disease” neuropathic pain or itch
  • mechanisms of neuropathic pain can also be assessed in humans, particularly through human surrogate models, multiple diagnostic tests exploring small or large fiber function, functional brain imaging or magnetic resonance
  • non-pharmacological approaches such as new neurostimulation techniques
  • psychological aspects, with reviews focusing on the fear of pain in children and adolescents and the importance of placebo and nocebo in neuropathic pain